A Patient Registry of patients with high-risk neuroblastoma being treated with the monoclonal antibody dinutuximab beta

First published 31/10/2019

Last updated 12/08/2026

EU PAS number:

EUPAS31973

Study

Ongoing

Download as PDF

Documents

Study protocol

No information provided.

Study results

No information provided.

Study report

No information provided.

ENCePP Seal

The use of the ENCePP Seal has been discontinued since February 2025. The ENCePP Seal fields are retained in the display mode for transparency but are no longer maintained.

No information provided.

A Patient Registry of patients with high-risk neuroblastoma being treated with the monoclonal antibody dinutuximab beta

Secondary tabs

Share this page